The AI Impact with Generate:Biomedicines' Mike Nally
Business Of Biotech
00:00
AI in Drug Discovery: Challenges and Advancements
The chapter discusses the potential of AI in drug discovery, emphasizing the need to differentiate companies truly leveraging AI from those capitalizing on hype. It delves into evaluating the quality of technology and personnel in biomedicine and stresses the importance of meaningful technology for improving patient outcomes. The speakers express confidence in the future impact of AI technologies, highlighting the necessity of caution, validation, and learning from failures in the biotech industry.
Transcript
Play full episode
